DeepMed Research

ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website: http://www.sj-hospital.org

Clinical Trials

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Phase 2

Not yet recruiting

Conditions: Breast Neoplasms

Interventions: Drug: Chidamide combined with exemestane (+/- goserelin)
Drug: Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)

First Posted Date: 2022-02-23

Last Posted Date: 2022-02-23

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 130

Registration Number: NCT05253066

Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: SLNB
Procedure: ALND
Procedure: pALND

First Posted Date: 2022-02-15

Last Posted Date: 2022-02-15

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 100

Registration Number: NCT05241119

Locations: 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
🇨🇳
Jianyi Li, Shenyang, Liaoning, China

Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole

First Posted Date: 2022-02-08

Last Posted Date: 2022-09-13

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 12

Registration Number: NCT05228951

Locations: 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

The Effect of Gravity on the Occurrence of Lactational Mastitis

Conditions: Lactation Mastitis

Interventions: Other: provides guidance on gravitationally assisted breastfeeding

First Posted Date: 2022-01-26

Last Posted Date: 2022-01-26

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 2000

Registration Number: NCT05207241

Locations: 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China

the Relationship Between Vertebral Body Length, Subarachnoid Space Width and Block Level

Conditions: Combined Spinal Epidurai Anesthesia
Lower Extremity Surgery

Interventions: Device: ltrasonic measure

First Posted Date: 2022-01-21

Last Posted Date: 2022-01-21

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 50

Registration Number: NCT05201261

Psychological Screening and Nursing of Twin Pregnancy

Not Applicable

Recruiting

Conditions: Twin; Complicating Pregnancy
Psychology

Interventions: Other: Guided self help
Other: Problem solving therapy
Other: Professional psychological intervention
Other: Face to face PST course

First Posted Date: 2022-01-10

Last Posted Date: 2022-01-19

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 100

Registration Number: NCT05182541

Locations: 🇨🇳
Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning, China

The Relationship Between Different Doses of Propofol and the Occurrence of Dreams in Short Surgery Under General Anesthesia

Not Applicable

Completed

Conditions: Dreaming
General Anesthesia

Interventions: Drug: Propofol

First Posted Date: 2021-12-30

Last Posted Date: 2022-06-02

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 300

Registration Number: NCT05173688

Locations: 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China

Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: SHR-1316 at a dose 20mg/kg q3w
Drug: SHR6390 at a dose of 150mg orally, daily
Radiation: SBRT

First Posted Date: 2021-11-24

Last Posted Date: 2024-01-03

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 24

Registration Number: NCT05132790

Locations: 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

Recruiting

Conditions: Deterioration, Clinical
Pulmonary Embolism and Thrombosis

First Posted Date: 2021-10-28

Last Posted Date: 2025-04-08

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 300

Registration Number: NCT05098769

Locations: 🇨🇳
Shenjing Hospital of CHINA MEDICAL UNIVERSITY, Shenyang, Liaoning, China

Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer

Phase 2

Conditions: HER2-positive Gastric Cancer

Interventions: Drug: Camrelizumab +Pyrotinib + Nab-paclitaxel + Tegafur

First Posted Date: 2021-10-07

Last Posted Date: 2021-10-07

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 35

Registration Number: NCT05070598

Locations: 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy